Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock
CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.01−0.37 (-10.81%)
Close on Nov 17, 2026Market cap $58.22MP/E –Yield –
Corbus Pharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Corbus Pharmaceuticals's total debt was $12.76M at Mar 31, 2024. For fiscal 2023 it was $15.91M, down 15.3% from the year before. The highest annual figure on record is $18.78M in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $15.91M | -15.3% |
| FY2022 | Dec 31, 2022 | $18.78M | +0.3% |
| FY2021 | Dec 31, 2021 | $18.73M | +3.9% |
| FY2020 | Dec 31, 2020 | $18.03M | – |
| FY2015 | Dec 31, 2015 | $0 | – |
| FY2014 | Dec 31, 2014 | $0 | -100.0% |
| FY2013 | Dec 31, 2013 | $331.24K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024 | Mar 31, 2024 | $12.76M | -32.7% |
| Q4 FY2023 | Dec 31, 2023 | $15.91M | -15.3% |
| Q3 FY2023 | Sep 30, 2023 | $17.85M | -7.4% |
| Q2 FY2023 | Jun 30, 2023 | $18.34M | -3.9% |
| Q1 FY2023 | Mar 31, 2023 | $18.98M | +0.4% |
| Q4 FY2022 | Dec 31, 2022 | $18.78M | +0.3% |
| Q3 FY2022 | Sep 30, 2022 | $19.27M | +3.9% |
| Q2 FY2022 | Jun 30, 2022 | $19.09M | +3.9% |
| Q1 FY2022 | Mar 31, 2022 | $18.91M | +3.9% |
| Q4 FY2021 | Dec 31, 2021 | $18.73M | +3.9% |
| Q3 FY2021 | Sep 30, 2021 | $18.55M | +3.9% |
| Q2 FY2021 | Jun 30, 2021 | $18.37M | – |
| Q1 FY2021 | Mar 31, 2021 | $18.20M | – |
| Q4 FY2020 | Dec 31, 2020 | $18.03M | – |
| Q3 FY2020 | Sep 30, 2020 | $17.86M | – |
See a number that looks wrong?